Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial

Autor: Nicholas I Paton, Joseph Musaazi, Cissy Kityo, Stephen Walimbwa, Anne Hoppe, Apolo Balyegisawa, Jesca Asienzo, Arvind Kaimal, Grace Mirembe, Abbas Lugemwa, Gilbert Ategeka, Margaret Borok, Henry Mugerwa, Abraham Siika, Eva Laker A Odongpiny, Barbara Castelnuovo, Agnes Kiragga, Andrew Kambugu, Daniel Kiiza, John Kisembo, John Nsubuga, Max Okwero, Rhona Muyise, Claire Nasaazi, Dridah L. Nakiboneka, Josephine Namusanje, Theresa Najjuuko, Timothy Masaba, Timothy Serumaga, Adolf Alinaitwe, Allan Arinda, Angela Rweyora, Mary Goretti Kangah, Mariam Kasozi, Phionah Tukumushabe, Rogers Akunda, Shafic Makumbi, Sharif Musumba, Sula Myalo, John Ahuura, Annet Mary Namusisi, Daniel Kibirige, Francis Kiweewa, Habert Mabonga, Joseph Wandege, Josephine Nakakeeto, Sharon Namubiru, Winfred Nansalire, Abraham Mosigisi Siika, Charles Meja Kwobah, Chris Sande Mboya, Martha Mokeira Bisieri Mokaya, Mercy Jelagat Karoney, Priscilla Chepkorir Cheruiyot, Salinah Cherutich, Simon Wachira Njuguna, Viola Cherotich Kirui, Ennie Chidziva, Godfrey Musoro, James Hakim, Joyline Bhiri, Misheck Phiri, Shepherd Mudzingwa, Tadios Manyanga, Anchilla Mary Banegura, Betty Agwang, Brian Isaaya, Constantine Tumwine, Eva Laker A. Odongpiny, Nicholas Paton, Peter Senkungu, Yvonne Kamara, Mathius Amperiize, Elizabeth Allen, Charles Opondo, Perry Mohammed, Willemijn van Rein-van der Horst, Yvon Van Delft, Fafa Addo Boateng, Doreen Namara, Pontiano Kaleebu, Sylvia Ojoo, Tapiwanashe Bwakura, Milly Katana, Francois Venter, Sam Phiri, Sarah Walker

Publikováno v: The Lancet HIV. 9:e381-e393

WHO guidelines recommend dolutegravir plus two nucleoside reverse transcriptase inhibitors (NRTIs) for second-line HIV therapy, with NRTI switching from first-line tenofovir to zidovudine. We aimed to examine whether dolutegravir is non-inferior to d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9294a359496eae0df6d04748de07b343
https://doi.org/10.1016/s2352-3018(22)00092-3

A Mixed Methods, Observational Investigation of Physical Activity, Exercise, and Diet Among Older Ugandans Living With and Without Chronic HIV Infection.

Autor: Wright CH; Chelsea H. Wright, MD, is a Family Medicine Resident, MetroHealth Medical Center, Cleveland, Ohio, USA. Chris T. Longenecker, MD, FAHA, is an Associate Professor of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Rashidah Nazzindah, MBChB, PhD, is a Physician, Joint Clinical Research Center, Kampala, Uganda. Cissy Kityo, MBChB, PhD, is a Director, Joint Clinical Research Center, Kampala, Uganda. Theresa Najjuuko, BSN, is a Research Nurse, Joint Clinical Research Center, Kampala, Uganda. Kirsten Taylor, is an Undergraduate Student, Case Western Reserve University College of Arts and Sciences, Cleveland, Ohio, USA. Cynthia Robin Rentrope, MSSA, MPH, LSW, is a Research Assistant IV, Case Western Reserve University, Cleveland, Ohio, USA. Allison Webel, RN, PhD, FAAN, is an Associate Professor of Nursing, Case Western Reserve University, Cleveland, Ohio, USA., Longenecker CT, Nazzindah R, Kityo C, Najjuuko T, Taylor K, Rentrope CR, Webel A

Publikováno v: The Journal of the Association of Nurses in AIDS Care : JANAC [J Assoc Nurses AIDS Care] 2021 Nov-Dec 01; Vol. 32 (6), pp. 640-651.